BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• BioCapital

  Chindex International, Inc. to Report Financial Results for the Third Quarter and First Nine Months of 2012

  October 25, 2012

   · 

  1 min read
• Business

  RTI Biologics Announces 2012 Third Quarter Results

  October 25, 2012

   · 

  1 min read
• Business

  Celgene Corporation Reports Third Quarter 2012 Operating and Financial Results

  October 25, 2012

   · 

  1 min read
• Biotech Beach

  Cytori Therapeutics, Inc. Release: Cardiovascular and Chronic Liver Disease Cell Therapy Clinical Studies Approved in Japan

  October 25, 2012

   · 

  1 min read
• Business

  AptarGroup Declares Quarterly Dividend; Confirms Third Quarter Conference Call

  October 25, 2012

   · 

  1 min read
• Drug Development

  Celgene International Sárl Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients

  October 25, 2012

   · 

  1 min read
• BioMidwest

  NeoChord’s Mitral Valve Repair Device to Be Featured at 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS)

  October 25, 2012

   · 

  1 min read
• Pharm Country

  Vasomedical Inc. Announces Application for Listing on the OTC Bulletin Board (“OTCBB”)

  October 25, 2012

   · 

  1 min read
• BioCapital

  HemoShear, LLC Closes $4 Millions in Series C Equity Financing to Support Growth

  October 25, 2012

   · 

  1 min read
• Drug Development

  Zalicus Inc. Licensee, Sanofi (France) Provides Status Update on Prednisporin (FOV1101)

  October 25, 2012

   · 

  1 min read